Generation Bio Co at Jefferies Cell & Genetic Medicine Summit Transcript
Today, it is my great pleasure to host a fireside chat with Geoff McDonough, President and CEO of Generation Bio. Thank you very much for joining us.
Questions & Answers
So to begin, Geoff, could you please provide a quick overview of Generation Bio and Generation Bio's differentiated non-viral gene therapy platform?
Thank you, Nalin, for the invitation to be here and for hosting. It's a pleasure to join you guys.
The way we think about non-viral, genetic medicine is in three waves of modality evolution. The first was originated by Alnylam, which is silencing RNA. They provided redosable, durable loss of function or knockdown. And the next wave of that non-viral, genetic medicine evolution came with Moderna and others, bringing messenger RNA, which was also redosable, but really brought gain of function to genetic medicines, and traded off durability with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |